John Carroll, founder and editor of Endpoints News, with Sebastian Guth, Bayer Pharmaceuticals' president for the Americas, at an Endpoints News event in San Diego on June 14, 2022
July 21, 2022 10:27 AM EDTUpdated 11:04 AM
Publisher's note

Con­nect with End­points News — here's our ma­jor event cal­en­dar com­ing up in H2 2022

Arsalan Arif

Founder

The room was packed and elec­tric. That’s how it felt host­ing an event in per­son for End­points News read­ers last month in San Diego …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Mer­ck’s long-await­ed obe­si­ty move is an oral GLP-1 from Chi­na

Ma­jor PBM re­forms fea­ture in Con­gress' year-end spend­ing bill

What Trump’s FTC picks mean for bio­phar­ma deal­mak­ing and PBMs

Up­dat­ed: Ver­tex’s non-opi­oid pill dis­ap­points in mid-stage chron­ic pain study

A service from the Financial Times